Ensartinib (X-396) in ALK-Positive Non-Small Cell Lung Cancer: Results from a First-in-Human Phase I/II, Multicenter Study von Horn, Leora, Infante, Jeffrey R, Reckamp, Karen L, Blumenschein, George R, Leal, Ticiana A, Waqar, Saiama N, Gitlitz, Barbara J, Sanborn, Rachel E, Whisenant, Jennifer G, Du, Liping, Neal, Joel W, Gockerman, Jon P, Dukart, Gary, Harrow, Kimberly, Liang, Chris, Gibbons, James J, Holzhausen, Allison, Lovly, Christine M, Wakelee, Heather A

Volltext

The Mammalian Target of Rapamycin Signaling Pathway: Twists and Turns in the Road to Cancer Therapy von ABRAHAM, Robert T, GIBBONS, James J

Volltext

Targeting mTOR globally in cancer: Thinking beyond rapamycin von Shor, Boris, Gibbons, James J., Abraham, Robert T., Yu, Ker

Volltext

Biochemical, Cellular, and In vivo Activity of Novel ATP-Competitive and Selective Inhibitors of the Mammalian Target of Rapamycin von KER YU, TORAL-BARZA, Lourdes, COLE, Derek C, ELLINGBOE, John, AYRAL-KALOUSTIAN, Semiramis, MANSOUR, Tarek S, GIBBONS, James J, ABRAHAM, Robert T, NOWAK, Pawel, ZASK, Arie, SHI, Celine, ZHANG, Wei-Guo, LUCAS, Judy, SHOR, Boris, KIM, Jamie, VERHEIJEN, Jeroen, CURRAN, Kevin, MALWITZ, David J

Volltext

A new pharmacologic action of CCI-779 involves FKBP12-independent inhibition of mTOR kinase activity and profound repression of global protein synthesis von Shor, Boris, Zhang, Wei-Guo, Toral-Barza, Lourdes, Lucas, Jessica, Abraham, Robert T, Gibbons, James J, Yu, Ker

Volltext

Hybrid Inhibitors of Phosphatidylinositol 3-Kinase (PI3K) and the Mammalian Target of Rapamycin (mTOR): Design, Synthesis, and Superior Antitumor Activity of Novel Wortmannin−Rapam... von Ayral-Kaloustian, Semiramis, Gu, Jianxin, Lucas, Judy, Cinque, Michael, Gaydos, Christine, Zask, Arie, Chaudhary, Inder, Wang, Jianyao, Di, Li, Young, Mairead, Ruppen, Mark, Mansour, Tarek S, Gibbons, James J, Yu, Ker

Volltext

microtubule-active antitumor compound TTI-237 has both paclitaxel-like and vincristine-like properties von Beyer, Carl F, Zhang, Nan, Hernandez, Richard, Vitale, Danielle, Nguyen, Thai, Ayral-Kaloustian, Semiramis, Gibbons, James J

Volltext

Enhanced Sensitivity of PTEN-Deficient Tumors to Inhibition of FRAP/mTOR von Neshat, Mehran S., Mellinghoff, Ingo K., Tran, Chris, Stiles, Bangyan, Thomas, George, Petersen, Roseann, Frost, Philip, Gibbons, James J., Wu, Hong, Sawyers, Charles L.

Volltext

ATP-Competitive Inhibitors of the Mammalian Target of Rapamycin: Design and Synthesis of Highly Potent and Selective Pyrazolopyrimidines von Zask, Arie, Verheijen, Jeroen C, Curran, Kevin, Kaplan, Joshua, Richard, David J, Nowak, Pawel, Malwitz, David J, Brooijmans, Natasja, Bard, Joel, Svenson, Kristine, Lucas, Judy, Toral-Barza, Lourdes, Zhang, Wei-Guo, Hollander, Irwin, Gibbons, James J, Abraham, Robert T, Ayral-Kaloustian, Semiramis, Mansour, Tarek S, Yu, Ker

Volltext

Phase I/II trial of X-396, a novel anaplastic lymphoma kinase (ALK) inhibitor, in patients with ALK+ non-small cell lung cancer (NSCLC) von Reckamp, Karen L., Infante, Jeffrey R., Blumenschein, George R., Wakelee, Heather, Carter, Corey A., Gockerman, Jon P., Lovly, Christine, Dukart, Gary, Harrow, Kimberly, Liang, Chris, Gibbons, James J., Horn, Leora

Volltext

Dans les couloirs du Vatican / Guy de Pierrefeu ; introduction par le cardinal Gibbons von Auschitzky, Daniel (1864-1937). Auteur du texte

Volltext bestellen

Abstract CT088: Phase I/II trial of X-396, a novel anaplastic lymphoma kinase (ALK) inhibitor, in patients with ALK+ non-small cell lung cancer (NSCLC) von Lovly, Christine M., Infante, Jeffrey R., Blumenschein, George R., Reckamp, Karen, Wakelee, Heather, Carter, Corey A., Waqar, Saiama N., Neal, Joel, Gockerman, Jon P., Dukart, Gary, Harrow, Kimberly, Liang, Chris, Gibbons, James J., Horn, Leora

Volltext

Plasma genotyping of patients enrolled on the expansion phase I/II trial of X-396 in patients (pts) with ALK+ non-small cell lung cancer (NSCLC) von Horn, Leora, Wakelee, Heather A., Reckamp, Karen L., Blumenschein, George R., Infante, Jeffrey R., Carter, Corey Allan, Waqar, Saiama Naheed, Neal, Joel W., Gockerman, Jon P, Harrow, Kimberly, Dukart, Gary, Liang, Chris, Gibbons, James J., Hernandez, Jennifer, Newman-Eerkes, Tara, Lim, Lee, Lovly, Christine Marie

Volltext

Abstract B145: Highly selective pyrazolopyrimidine mTOR inhibitors with profound in vivo antitumor activity von Zask, Arie, Kaplan, Joshua, Curran, Kevin, Verheijen, Jeroen C., Richard, David J., Brooijmans, Natasja, Bennett, Eric, Lucas, Judy, Toral-Barza, Lourdes, Hollander, Irwin, Gibbons, James J., Abraham, Robert T., Ayral-Kaloustian, Semiramis, Mansour, Tarek S., Yu, Ker

Volltext

Interscalene Blocks for Chronic Upper Extremity Pain von Gibbons, James J, Wilson, Peter R, Lamer, Tim J, Elliott, Beth A

Volltext

Pluronic F 127 liquid sensitizes mice to low doses of Escherichia coli lipopolysaccharide von PICKETT, WALTER C, TORLEY, LAWRENCE W, DEJOY, SUSAN QUINN, GIBBONS, JAMES J, DESAI, NARENDRA R, ORONSKY, ARNOLD L, KERWAR, S S

Volltext

Thermodynamics of aqueous mixed potassium carbonate, bicarbonate, and chloride solutions to 368 K von Simonson, John M, Roy, Rabindra N, Gibbons, James J

Volltext

Thermodynamics of aqueous magnesium and calcium bicarbonates and mixtures with chloride von Pitzer, Kenneth S, Olsen, Joyce, Simonson, John M, Roy, Rabindra N, Gibbons, James J, Rowe, LeAnn

Volltext

The thermodynamics of aqueous carbonate solutions II. Mixtures of potassium carbonate, bicarbonate, and chloride von Roy, Rabindra N, Gibbons, James J, Williams, Rick, Godwin, Lehman, Baker, Gigi, Simonson, John M, Pitzer, Kenneth S

Volltext

Antineoplastic combinations von JR., JAMES J. GIBBONS, SRIDHAR KRISHNA RABINDRAN

Volltext bestellen